✦ LIBER ✦

Chemotherapy trials in head and neck cancer to the editor

✍ Scribed by Marco Merlano

Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 126 KB
Volume: 17
Category: Article
ISSN: 1043-3074
DOI: 10.1002/hed.2880170317

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Chemotherapy trials in head and neck can

Chemotherapy trials in head and neck cancer

✍ Samuel G. Taylor IV; Arlene A. Forastiere 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB 👁 2 views

Chemotherapy trials, head and neck cance

Chemotherapy trials, head and neck cancer, and quality of life

✍ Randall P. Morton 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 289 KB 👁 2 views

Induction chemotherapy in the management

Induction chemotherapy in the management of head and neck cancer

✍ Matthew G. Fury; Jatin P. Shah 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 105 KB 👁 1 views

Chemotherapy in the treatment of locally

Chemotherapy in the treatment of locally advanced head and neck cancer

✍ Arlene A. Forastiere 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 1 views

Editorials. Chemotherapy trials in head

Editorials. Chemotherapy trials in head and neck cancer: Where are we, and where are we going?

✍ Randal S. Weber 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB

Phase 1 trial of combined chemotherapy a

Phase 1 trial of combined chemotherapy and reirradiation for recurrent unresectable head and neck cancer

✍ Sharon Spencer; Richard Wheeler; Glenn Peters; Ruby Meredith; Sam Beenken; Lisle 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 2 views

## Abstract ## Background. The management of recurrent unresectable head and neck cancer remains a challenging problem. Based on the circadian rhythm concept, we sought to determine the maximum tolerated dose (MTD) of infusional 5‐flourouracil (5‐FU), hydroxyurea (HU), and reirradiation (RT). ##